పబ్లిక్ హెల్త్ పాలసీ అండ్ ప్లానింగ్ జర్నల్

నైరూప్య

Prevention and mitigation of congenital toxoplasmosis: Monetary prices and benefits in various settings.

Julia Quinn*

Congenital toxoplasmosis (CT), the result of a primary infection of pregnant ladies with Toxoplasma gondii which turned into transmitted to the foetus, may result in slight to deep injuries taking place within the new child or later in its improvement or in youth. The visual and cognitive impairment which can result imposes vast economic fees at the man or woman and society. numerous observational studies prefer the realization that, with preventive measures currently available, it's miles feasible to lessen the incidence of infections in pregnant women, the prevalence of foetal contamination by preventing trans placental transmission, and the gravity of injury in inflamed new-borns. Treatment of inflamed new-borns also can lessen the severity of effects and the frequency of their occurrence later in life. Prevention applications, but, are carried out in just a few international locations; in maximum nations implementation of a national prevention program has now not been considered or has been thought to be too luxurious. This text lists the strategies of prevention of CT and describes current country wide prevention packages in France and Austria. It analyses the monetary expenses and benefits of maternal screening for CT prevention and mitigation for society and for health systems. New diagnostic tools are mentioned and the implication of decrease charges is taken into consideration, for countries with properly-hooked up screening applications in addition to those with insufficient prenatal care networks.

నిరాకరణ: ఈ సారాంశం ఆర్టిఫిషియల్ ఇంటెలిజెన్స్ టూల్స్ ఉపయోగించి అనువదించబడింది మరియు ఇంకా సమీక్షించబడలేదు లేదా నిర్ధారించబడలేదు.